Home Health Costs Topics

Health Costs

The MIDTERMS

“...the search for a single top issue through polling questions — whether it’s health costs, or gas prices, or the cost of food — is artificial. People worry about and experience these costs together. There is no top issue, unless that issue is the catchall, ‘cost of living.’” — Drew Altman, KFF Founding President and CEO

Are Health Care Costs THE Top Issue for Voters?

In a new column, Dr. Drew Altman, Founding President and CEO, analyzes the polling on health costs as a voting issue and concludes that there is no one top voting issue. He writes: “I have come to the conclusion that the search for a single top issue through polling questions—whether it’s health costs, or gas prices, or the cost of food—is artificial. People worry about and experience these costs together. There is no top issue, unless that issue is the catchall, “cost of living.”

Health System Tracker

Small Businesses Could See Double-Digit Premium Increases in 2027, According to Insurers’ Preliminary Rate Filings

Nearly 300 insurers offering offering health coverage to small businesses reported a median proposed premium increase of 14% for next year, according to an analysis of preliminary rate filings from all 50 states and DC.

ACA Marketplace Insurers Are Proposing a Median Premium Increase of About 15% in 2027

ACA Marketplaces insurers are proposing a median premium increase of 15% in 2027, according to an updated analysis of 276 insurers with publicly available filings across all 50 states and the District of Columbia.

In 2024, life expectancy in the U.S. reached an all-time high of 79 years but remained years behind the average in comparable countries

Life expectancy at birth in the U.S. increased 0.6 years from 78.4 years in 2023 to 79.0 years in 2024, its highest-ever level. However, the average life expectancy in comparable countries was about 3.7 years longer than in the U.S.

Among adults 18 - 64 with private insurance, mental health and substance use treatment accounted for 10% of all overnight stays at hospitals or other medical facilities in 2023.

Using claims data from the 2023 Merative MarketScan Commercial Claims Database, this analysis describes the most common diagnoses for inpatient treatment and total associated costs, including patients’ out-of-pocket share.

New and noteworthy

How Unaffordable is Health Care and What Can We Do About It?

Event Date:

On Tuesday, July 21, three experts joined Health Wonk Shop series moderator Larry Levitt in an hour-long discussion of health care affordability. During the discussion, panelists considered affordability from a variety of perspectives, including how to define affordability and the question of affordability for whom, how to measure it, and what can be done to address affordability and the underlying cost of health care.

Latest News

More KFF Health News

Stay informed.

Get KFF's latest on Health Costs

Stay informed.

Get KFF's latest on Health Costs

View the Latest: Health Costs

Filter

List Grid

711 - 720 of 1,603 Results

  • Chartpack: National Survey of Enrollees in Consumer-Directed Health Plans

    Poll Finding

    This chart pack provides data and analysis from the National Survey of Enrollees in Consumer-Directed Health Plans conducted between June 21 and July 10, 2006. The survey looks at the views and experiences of people enrolled in consumer-directed health plans as compared to people with traditional health insurance. Chartpack (.pdf)

  • Public Views on Direct-to-Consumer Prescription Drug Advertising

    Poll Finding

    Mollyann Brodie, Kaiser vice president and director of Public Opinion and Media Research, testified before the House Energy and Commerce Subcommittee on Oversight and Investigations about the public's views of prescription drugs, the pharmaceutical industry, and direct-to-consumer drug advertising. Brodie's testimony was a part of the hearing titled, "Direct-to-Consumer Advertising: Marketing, Education, or Deception?" Testimony (.pdf)

  • How Build Back Better Would Affect Drug Costs

    Feature

    Provisions in the bill that would lower prescription drug costs and reduce federal drug spending would take effect over the next several years, starting in 2023.

  • KFF’s Kaiser Health News Investigates Private Equity’s Stealth Takeover of Health Care in the United States

    News Release

    A new investigation by KFF’s Kaiser Health News (KHN) lays bare the sizeable efforts by private equity investors to take over large and lucrative parts of the U.S health care system in recent years. KHN found that private equity firms have invested nearly $1 trillion through thousands of deals to acquire hospitals and specialized medical practices during the last decade alone. The deals, many of them unnoticed by federal regulators, typically result in a ratcheting…

  • Analysis: Inconsistencies Within Hospital Price Transparency Data Make Cost Comparisons Difficult

    News Release

    Since 2021, federal law has required hospitals to publicly post information about their standard prices and negotiated discount rates for common health services to encourage consumers to compare prices and to promote competition. To date, however, the transparency data currently shared by hospitals to comply with the law are messy, inconsistent and confusing, making it challenging, if not impossible, for patients or researchers to use them to compare prices across hospitals or payers, a new…

  • Gross Medicare Spending on Ozempic and Other GLP-1s Is Already Skyrocketing – Even Though Medicare Cannot Cover The Drugs for Weight Loss

    News Release

    A KFF analysis shows that gross total Medicare spending on Ozempic and other similar drugs has increased dramatically in recent years – even though Medicare is explicitly prohibited by law from covering the drugs for obesity. That’s because Medicare now covers the drugs, known as GLP-1s, for other medically accepted indications, including to treat diabetes. This week the Centers for Medicare & Medicaid Services (CMS) informed Medicare drug plans that they can cover Wegovy, another…

  • How Marketplace Costs and Premiums Will Change if American Rescue Plan Subsidies Expire

    News Release

    In a new Policy Watch, KFF analysts explore the potential impact of the expiration of the American Rescue Plan Act’s enhanced financial help and new eligibility for the Affordable Care Act’s health insurance Marketplace federal subsidies. While the COVID-19 relief legislation passed earlier this year provides greater subsidy assistance through 2022, Democrats in Congress are currently considering making the temporary federal help permanent or extending it as part of their planned budget reconciliation legislation. The…

  • Nov. 10 Web Briefing to Release the 2021 Employer Health Benefits Survey Capturing Trends in Offer Rate, Premiums, Cost Sharing and Benefit Changes Related to COVID-19

    Event Date:
    Event

    KFF released its 2021 benchmark Employer Health Benefits Survey via a public web briefing on Nov. 10, 2021. This 23rd annual survey provided a detailed look at the current state of employer-based coverage and trends in private health insurance for both large and small firms. Fielded among a nationally representative sample of nearly 1,700 employers with at least three workers, the survey captures average premiums for workers and employers and their rate of increase; average…

  • What to Know About the FDA’s Recent Decision to Allow Florida to Import Prescription Drugs from Canada

    Policy Watch

    Florida’s plan to import certain prescription drugs from Canada represents the first time the Food and Drug Administration (FDA) has granted authority for a state to safely import prescription drugs from another country. This policy watch analysis unpacks some frequently asked questions related to state of Florida’s importation plan, including potential obstacles to implementation, who will benefit from any savings, and what types of drugs will (and will not) qualify for importation.